| Name | Title | Contact Details |
|---|
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Tracklib is the only service where anyone can legally clear samples from real music. From Isaac Hayes to Mozart, we got it.
THH LLC is a company that specializes in starting up and scaling service related businesses. They provide custom software development, technology integration, cloud management and virtual technology solutions.
LiveTechnology is a single platform that manages communications across 49 forms of media (tv, etc), ensuring all communications, marketing and advertising are on-brand, on-message, relevant and legally compliant. .
Credly is the leading digital credential service provider, helping the world recognize lifelong achievement with the most popular platforms for verifying, sharing, and managing digital credentials and badges.